Semaglutide Peak: What Happens After Each Injection

The decision most people are actually making: when to inject and what to expect afterwards

When people ask about the semaglutide peak, they are usually trying to solve something practical. They want to know whether that queasy Tuesday morning is normal, whether they should move their injection day so the peak lands on a quieter part of the week, or whether the appetite suppression they feel on day two will last. These are real questions, and the pharmacokinetics give real answers.

Semaglutide is a GLP-1 receptor agonist. After injection it is absorbed slowly from subcutaneous tissue, which is precisely why the peak comes a day or more later rather than within hours. The NHS's patient-level guidance on semaglutide explains the once-weekly schedule in plain terms: the medicine is designed to maintain steady levels across the whole week, not to spike and crash like a short-acting drug. That steady profile is a feature, not an accident.

Practically, this means the 24–72 hour window post-injection is when you are most likely to notice nausea, a reduced appetite, or a feeling of fullness after eating very little. By day four or five, those effects tend to be gentler. Then the cycle begins again. Knowing this rhythm helps you plan: if Friday's injection means Saturday and Sunday are the most nauseous days, and those happen to be busy with a family weekend, it is worth discussing whether a mid-week injection day would suit you better. That is a conversation for your prescriber, not a change to make unilaterally.

Why the half-life matters more than the peak alone

The peak concentration tells you when semaglutide is at its highest in your blood. The half-life tells you how long it takes for that level to halve. For semaglutide, the half-life is approximately one week, which is unusually long for a GLP-1 medicine. The consequence is clinically significant: even as levels fall from their peak, they remain high enough to activate GLP-1 receptors and suppress appetite throughout the full seven days.

This is meaningfully different from shorter-acting GLP-1 drugs used in diabetes (daily injections, much shorter half-lives) and it is part of why semaglutide's once-weekly design works for weight management. You are not dependent on the peak itself for the drug's effect — the sustained trough concentration does a lot of the work. For practical timing questions around exactly when that peak lands, our detailed page on semaglutide peak timing covers the pharmacokinetic data in more depth.

The long half-life also means that if you miss a dose, semaglutide does not disappear from your system immediately. That said, missed doses should be handled as described in the Patient Information Leaflet and discussed with your prescriber, the guidance is specific to your dose level and how close you are to the next scheduled injection.

How the peak changes as your dose increases

Wegovy's titration schedule starts at 0.25 mg and steps upward through 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg over several months. With a higher dose comes a higher peak concentration, and for some people, more pronounced side effects around days one to three post-injection at each new level. This is the main reason the schedule is gradual: it gives your gastrointestinal system time to adapt before the peak climbs further.

A lot of patients tell us that the first week at a new dose is the hardest, and that things ease noticeably by the second or third injection at that level. That pattern fits the pharmacology. How the timing of semaglutide's peak shifts with dose is something our prescribers discuss routinely with patients, particularly at the transition to 1.7 mg and 2.4 mg, where the jump in peak concentration is larger.

For context on what the clinical evidence says about what happens at maintenance dose (2.4 mg), the STEP 1 trial (published in the New England Journal of Medicine) found an average weight reduction of around 15% over 68 weeks in adults without type 2 diabetes. That result emerged over time, built across many weekly cycles of peak and trough, not from any single injection.

Matching the peak to your life, and when to ask for help

Managing the peak is, in large part, about managing the side-effect window. A few things most people find useful: eating smaller, lower-fat meals in the 24–48 hours after injecting; staying well hydrated; and injecting at a time of day when a few hours of mild nausea would be least disruptive. Some people inject on a Sunday evening so the peak sits during a Monday when they are at their desk rather than somewhere the tablet before the kettle goes on would already feel like too much to ask.

Side effects that are severe, persistent beyond a few days at each dose, or that include significant vomiting, severe stomach pain, or any pain radiating to the back warrant prompt medical advice. If you are taking any over-the-counter medicines alongside your treatment, it is worth checking for interactions first, and our guide to taking Benadryl alongside Wegovy is a useful example of the kind of combination question our pharmacists are regularly asked. The MHRA's Yellow Card scheme allows patients to report any unexpected side effects, and doing so genuinely helps regulators monitor medicines in real-world use.

If you have questions about whether Wegovy is right for your situation, or how the dose schedule would work around your life, our free consultation puts you in front of a GPhC-registered prescriber, a named clinician reviews your case, not software. For broader context on what private treatment involves, and to understand when semaglutide is at its peak during your weekly cycle, the weight-loss treatment overview is a good starting point.